We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
(+18%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
13.91%
Top 10 Holdings %
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$4.02M |
| 2 |
Nike
NKE
|
+$3.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.69M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$3.63M |
| 5 |
Costco
COST
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$3.04M |
| 2 |
Visa
V
|
+$2.98M |
| 3 |
Procter & Gamble
PG
|
+$2.96M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$2.94M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.97% |
| 2 | Industrials | 12.49% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Staples | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RICE
1
DELISTED
Rice Energy Inc.
RICE
| $3.69M | 1.08% |
141,475
+126,700
| +858% | +$3.14M |
|
|
BNY
2
Bank of New York Mellon
BNY
$106B
| $3.62M | 1.06% |
+90,837
| New | +$3.63M |
|
3
RTX Corp
RTX
$293B
| $3.57M | 1.04% |
55,842
+36,229
| +185% | +$2.4M |
|
4
Cognizant
CTSH
$24B
| $3.56M | 1.04% |
74,608
+23,000
| +45% | +$1.31M |
|
5
Yum! Brands
YUM
$41.3B
| $3.56M | 1.04% |
54,527
+34,357
| +170% | +$2.19M |
|
|
6
Costco
COST
$432B
| $3.55M | 1.04% |
23,300
+21,100
| +959% | +$3.41M |
|
7
Qualcomm
QCOM
$175B
| $3.55M | 1.04% |
+51,795
| New | +$3.15M |
|
|
8
Teva Pharmaceuticals
TEVA
$36.6B
| $3.55M | 1.04% |
+77,100
| New | +$4.02M |
|
|
WR
9
DELISTED
Westar Energy Inc
WR
| $3.55M | 1.04% |
62,500
+9,900
| +19% | +$548K |
|
|
MON
10
DELISTED
Monsanto Co
MON
| $3.54M | 1.04% |
34,681
+6,100
| +21% | +$640K |
|
|
11
Nike
NKE
$63.9B
| $3.54M | 1.04% |
+67,300
| New | +$3.8M |
|
12
PepsiCo
PEP
$194B
| $3.54M | 1.03% |
32,500
+15,600
| +92% | +$1.68M |
|
13
Waste Management
WM
$96B
| $3.42M | 1% |
53,600
+49,500
| +1,207% | +$3.24M |
|
14
Accenture
ACN
$101B
| $3.4M | 0.99% |
27,800
+26,000
| +1,444% | +$2.96M |
|
|
LNKD
15
DELISTED
LinkedIn Corporation
LNKD
| $3.39M | 0.99% |
17,742
+14,100
| +387% | +$2.7M |
|
16
Conagra Brands
CAG
$7.38B
| $3.27M | 0.96% |
89,209
+63,993
| +254% | +$2.3M |
|
17
Molson Coors Class B
TAP
$7.96B
| $3.19M | 0.93% |
29,100
+11,700
| +67% | +$1.19M |
|
|
18
Bristol-Myers Squibb
BMY
$129B
| $3.12M | 0.91% |
57,859
+57,500
| +16,017% | +$3.69M |
|
19
Service Corp International
SCI
$11.8B
| $3.06M | 0.9% |
115,500
+93,300
| +420% | +$2.53M |
|
20
Danaher
DHR
$141B
| $3.03M | 0.88% |
43,564
+6,932
| +19% | +$491K |
|
|
MJN
21
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.96M | 0.87% |
+37,497
| New | +$3.2M |
|
22
Walt Disney
DIS
$172B
| $2.96M | 0.86% |
31,822
+20,400
| +179% | +$1.95M |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $2.93M | 0.86% |
28,000
-2,200
| -7% | -$238K |
|
24
Hershey
HSY
$36.9B
| $2.86M | 0.84% |
+29,900
| New | +$3.16M |
|
|
MRSH
25
Marsh
MRSH
$90.4B
| $2.73M | 0.8% |
+40,560
| New | +$2.72M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.
- Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
- Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
- Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
- Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
- Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
- Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.
Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.